Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 57901-57950 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT06553716
Ultrasound-Guided Hydrodilatation With Triamcinolone Acetonide for Adhesive Capsulitis
NARecruiting
70 participants
Started: Feb 5, 2024 · Completed: Nov 30, 2024
1 condition1 sponsor1 location
NCT06122389
SHR2554 Clinical Study of Chidamide in the Treatment of T-cell Lymphoma
PHASE3Recruiting
130 participants
Started: Feb 5, 2024 · Completed: Jul 31, 2026
1 condition1 sponsor1 location
NCT06255509
Dengue Virus Infection Amongst Patients With Acute Febrile Illness
N/ARecruiting
400 participants
Started: Feb 5, 2024 · Completed: Mar 31, 2025
1 condition1 sponsor1 location
NCT06269705
ZILRETTA in Subjects With Shoulder Osteoarthritis
PHASE3Recruiting
250 participants
Started: Feb 5, 2024 · Completed: Aug 31, 2025
1 condition1 sponsor32 locations
NCT06748495
Real-world First-line Serplulimab-based Immunochemotherapy for Extensive-stage Small Cell Lung Cancer
N/AActive, not recruiting
600 participants
Started: Feb 5, 2024 · Completed: Jun 6, 2025
1 condition1 sponsor1 location
NCT05903352
Customized Antibiotic Treatment Duration Among Hospitalized Patients With Moderately Severe Community-Acquired Pneumonia
PHASE3Recruiting
328 participants
Started: Feb 5, 2024 · Completed: May 31, 2027
1 condition1 sponsor1 location
NCT05261425
Suture Closure Trial
NAActive, not recruiting
160 participants
Started: Feb 5, 2024 · Completed: Oct 31, 2025
2 conditions1 sponsor3 locations
NCT06731855
An Exploratory Physiological Study of Post-operative Recovery in Surgical Neonates and Dimethylarginine:Arginine Levels
N/ARecruiting
30 participants
Started: Feb 5, 2024 · Completed: Feb 28, 2026
6 conditions2 sponsors2 locations
NCT06098482
An Investigation to Validate Speech Perception Assessment for Adult Cochlear Recipients Using a Mobile Research App
NARecruiting
46 participants
Started: Feb 5, 2024 · Completed: May 2, 2027
1 condition1 sponsor4 locations
NCT06270732
Efficacy of iMentalize and MISC-SA to Foster Parents' Mentalization and Children Mental Health in General Population.
NARecruiting
105 participants
Started: Feb 5, 2024 · Completed: Mar 3, 2025
4 conditions2 sponsors2 locations
NCT05910008
O-ARM Stereotactic Imaging in Deep Brain Stimulation for Parkinson's Disease
NARecruiting
24 participants
Started: Feb 5, 2024 · Completed: Jun 15, 2025
1 condition1 sponsor1 location
NCT06127589
"The Quit-for-Kids Project: to Increase Abstinence and Protect Children from Tobacco Smoke Exposure"
NARecruiting
1,200 participants
Started: Feb 5, 2024 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT06139601
A Single Session Community-Based Body Empowerment Session
NAActive, not recruiting
75 participants
Started: Feb 5, 2024 · Completed: Jul 31, 2025
1 condition1 sponsor1 location
NCT06263894
Alexander Technique on Labor Pain and Anxiety
NARecruiting
68 participants
Started: Feb 5, 2024 · Completed: Jul 2, 2024
2 conditions2 sponsors1 location
NCT05867979
Search for Structural Variants in Patients With DSD and Inconclusive Molecular Diagnosis
NARecruiting
20 participants
Started: Feb 5, 2024 · Completed: Feb 15, 2026
1 condition1 sponsor1 location
NCT06413277
Targeting the Conus Medullaris With ECAP-Controlled Closed-Loop SCS for Treatment of Chronic Pelvic Pain: HOPE Trial
N/ARecruiting
20 participants
Started: Feb 5, 2024 · Completed: Jan 1, 2027
2 conditions2 sponsors1 location
NCT06425094
Effects of a Microalgae Extract Dietary Supplement on Gut Health, Anxiety, and Immune Function
PHASE1Recruiting
60 participants
Started: Feb 5, 2024 · Completed: Dec 31, 2024
4 conditions2 sponsors1 location
NCT06217042
HR070803 in Combination With Oxaliplatin, 5-fluorouracil/LV Versus GX as Adjuvant Therapy for Pancreatic Cancer
PHASE3Not yet recruiting
524 participants
Started: Feb 5, 2024 · Completed: Jul 30, 2028
1 condition1 sponsor1 location
NCT06215963
A4i-O: A Platform for Complex Behavioral Health to Address OUD
NARecruiting
15 participants
Started: Feb 5, 2024 · Completed: Nov 30, 2024
5 conditions1 sponsor1 location
NCT06277427
Refractory ANCA Associated Vasculitis and Lupus Nephritis Treated With BCMA-targeting CAR-T Cells
NARecruiting
24 participants
Started: Feb 5, 2024 · Completed: Jan 31, 2027
2 conditions2 sponsors1 location
NCT06330727
Effects of Coffee Consumption on Metabolic Markers in Adults With Prediabetes and Obesity
NARecruiting
100 participants
Started: Feb 5, 2024 · Completed: Oct 31, 2024
1 condition1 sponsor1 location
NCT05944731
Use of Continuous Glucose Monitoring Devices Among People Living With Type 1 Diabetes in Kenya.
NANot yet recruiting
246 participants
Started: Feb 5, 2024 · Completed: Apr 28, 2025
1 condition3 sponsors0 locations
NCT06251817
The Wideband Acoustic Immittance Data in Thai Normal Hearing and Conductive Hearing Loss Adults
N/AEnrolling by invitation
290 participants
Started: Feb 5, 2024 · Completed: Feb 26, 2026
2 conditions3 sponsors1 location
NCT06250959
RDC-Blinatumomab Versus hyperCVAD for Ph-negative B-ALL.
PHASE2Recruiting
124 participants
Started: Feb 5, 2024 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT05957055
Lisdexamphetamine Vs Methylphenidate for Pediatric Patients with ADHD and Type 1 Diabetes
PHASE2Recruiting
150 participants
Started: Feb 5, 2024 · Completed: Dec 1, 2027
2 conditions5 sponsors1 location
NCT06199037
Safety and Pharmacodynamics of SHR-1707 in Alzheimer's Disease Patients
PHASE2Recruiting
45 participants
Started: Feb 5, 2024 · Completed: Jun 24, 2026
1 condition1 sponsor1 location
NCT06227377
QTX3034 in Patients With KRAS G12D Mutation
PHASE1Recruiting
250 participants
Started: Feb 5, 2024 · Completed: Apr 1, 2027
1 condition1 sponsor14 locations
NCT05762055
Prospective Comparative Analysis of ACDF vs Fusion Interbody Cages With nanoLOCK Osseointegrative Technology
NAEnrolling by invitation
200 participants
Started: Feb 5, 2024 · Completed: May 31, 2026
2 conditions2 sponsors1 location
NCT06246266
Effectiveness of Helfer Skin Tap Technique and ShotBlocker Technique
NANot yet recruiting
60 participants
Started: Feb 5, 2024 · Completed: Dec 31, 2024
1 condition1 sponsor0 locations
NCT05902208
Contribution of an Antiviral Drug (Valaciclovir) in the Treatment of Generalized Periodontitis (Stage III or IV and Grade A, B or C): Prospective, Randomized and Double Blind Clinical Trial
PHASE3Recruiting
142 participants
Started: Feb 5, 2024 · Completed: May 31, 2026
1 condition1 sponsor3 locations
NCT06317766
Histological Study of the Effects of a 2910 nm Fiber Laser Technology
NAEnrolling by invitation
2 participants
Started: Feb 5, 2024 · Completed: May 31, 2024
1 condition2 sponsors1 location
NCT06250751
Behavioral Exercise TRaining for Men Undergoing Androgen Depr Therapy for Prostate Ca
NAActive, not recruiting
27 participants
Started: Feb 5, 2024 · Completed: Sep 30, 2025
1 condition2 sponsors1 location
NCT07127224
Consciousness Prognosis Evaluation Using Olfactory Stimulations in Comatose Patients)
NARecruiting
96 participants
Started: Feb 5, 2024 · Completed: May 5, 2027
1 condition1 sponsor1 location
NCT06209879
Dual-Polymer Hydroxypropyl Guar-and Hyaluronic Acid Lubricants in Rheumatoid Arthritis
PHASE4Recruiting
40 participants
Started: Feb 5, 2024 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT06186752
Feasibility Test of Action Planning in Pediatric IBD
NARecruiting
60 participants
Started: Feb 5, 2024 · Completed: Mar 31, 2026
1 condition2 sponsors1 location
NCT06926504
TeamBirth-SWE - a Care Process to Improve Safe and Person-centered Intrapartum Care
N/ARecruiting
800,000 participants
Started: Feb 5, 2024 · Completed: Dec 31, 2029
3 conditions8 sponsors7 locations
NCT06280326
Effect of Different Materials Used in Orogastric Tube Removal on Skin Condition in Premature Babies
NAActive, not recruiting
86 participants
Started: Feb 5, 2024 · Completed: Aug 5, 2024
1 condition1 sponsor1 location
NCT06341426
Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression: Comparing One Versus Two Doses of Psilocybin
PHASE2Recruiting
92 participants
Started: Feb 5, 2024 · Completed: Aug 1, 2028
4 conditions2 sponsors1 location
NCT06244446
Efficacy and Safety of SBRT Combined With Atezolizumab Plus Bevacizumab vs Atezolizumab Plus Bevacizumab in Treating Unresectable Advance Hepatocellular Carcinoma.
N/ANot yet recruiting
40 participants
Started: Feb 5, 2024 · Completed: Jan 31, 2025
1 condition1 sponsor1 location
NCT06544083
Early-stage Detection of Liver Cancer by Proteins in Peripheral Blood
N/ARecruiting
300 participants
Started: Feb 5, 2024 · Completed: Feb 28, 2026
1 condition1 sponsor1 location
NCT06216730
Endoscopic Resection of Papillary Adenomas; a Novel Treatment Algorithm to Prevent Recurrence - a Pilot-study
NANot yet recruiting
20 participants
Started: Feb 5, 2024 · Completed: Jan 20, 2025
1 condition1 sponsor0 locations
NCT06220058
"Comparing Polypropylene Mesh and Small Bites Technique in Emergency Colorectal Surgery's Midline Laparotomy Closure. Study for Incisional Hernia Prevention."
NARecruiting
148 participants
Started: Feb 5, 2024 · Completed: Jan 15, 2027
3 conditions1 sponsor1 location
NCT05894824
T-Dxd in Combination With Ramucirumab as HER2 Low Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
PHASE1/PHASE2Recruiting
58 participants
Started: Feb 5, 2024 · Completed: Jan 1, 2026
2 conditions1 sponsor1 location
NCT06194734
A Study of KC1036 Versus Investigator's Choice of Chemotherapy in Patients With Advanced Esophageal Cancer
PHASE3Recruiting
490 participants
Started: Feb 5, 2024 · Completed: Dec 30, 2027
1 condition1 sponsor1 location
NCT06251570
Evaluation of Dual Task Performance and Respiratory Muscle Endurance in Patients With Lung Cancer
N/ANot yet recruiting
60 participants
Started: Feb 5, 2024 · Completed: Jul 30, 2024
1 condition1 sponsor0 locations
NCT06062966
The Effects of IL-1 Blockade on Inotrope Sensitivity in Patients With Heart Failure (AID-HEART)
PHASE1Recruiting
20 participants
Started: Feb 5, 2024 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT06198751
A Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer
PHASE2Active, not recruiting
104 participants
Started: Feb 5, 2024 · Completed: Feb 29, 2028
1 condition1 sponsor7 locations
NCT05726539
The Military Spouse Resiliency Group (MSRG) Peer Support Program: Equipping Families For Resiliency With Tools
NANot yet recruiting
150 participants
Started: Feb 5, 2024 · Completed: Dec 15, 2025
1 condition1 sponsor1 location
NCT06219070
Effect of Core Training on Physical Fitness and Smash Performance Among Female Badminton Players in Guangxi, China
NANot yet recruiting
40 participants
Started: Feb 5, 2024 · Completed: Aug 5, 2024
1 condition1 sponsor1 location
NCT05704829
NeoAdjuvant Therapy With Trastuzumab-deruxtecan Versus Chemotherapy+Trastuzumab+Pertuzumab in HER2+ Early Breast Cancer
PHASE2Recruiting
402 participants
Started: Feb 5, 2024 · Completed: Jun 30, 2028
1 condition2 sponsors43 locations